Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications

Cordyceps militaris offers a cultivable source of cordycepin, a pharmaceutically relevant nucleoside. This review integrates evidence on cultivation, cordycepin biosynthesis and regulation, artificial intelligence and omics applications, recovery, and biological activities, with emphasis on reproducible production and pharmaceutical development. Solid-state and submerged cultivation serve different production targets; however, cordycepin yield and product quality vary with strain, substrate, developmental stage, and process conditions. Cordycepin production depends on biosynthetic activity and protection against deamination associated with the cns1–cns4 cluster, precursor supply, and environmental regulation rather than on gene expression alone. Genetic engineering, metabolic modelling, multi-omics, machine learning, and process monitoring have supported production improvement, pathway analysis or prediction, but these approaches remain poorly integrated. The reviewed studies do not demonstrate validated online cordycepin estimation or autonomous control. Recovery methods involve trade-offs among yield, purity, cost, and throughput, highlighting the need for consistent product specifications. Cordycepin shows anticancer, anti-inflammatory, and antioxidant activities, although evidence remains preclinical and limited by variable experimental exposures, incomplete mechanistic validation, and insufficient pharmacokinetic and clinical data. Future progress requires standardized strains and cultivation protocols, causal metabolic validation, externally validated predictive models, integrated process control, scalable recovery, and translational evaluation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-16
DOI
https://doi.org/10.3390/ph19111822
Primary Topic
Fungal Biology and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications

Amritesh C. Shukla, Qazi Mohammad Sajid Jamal, Khurshid Ahmad, Harshita Gaurav et al.
1 links
Pharmaceuticals
Fungal Biology and Applications
article

Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications

Amritesh C. Shukla, Qazi Mohammad Sajid Jamal, Khurshid Ahmad, Harshita Gaurav, Divyanshu Yadav, Vijay Luxmi, Pradeep Kumar, Divya Singh, Shiva Tripathi
article en

Abstract

Cordyceps militaris offers a cultivable source of cordycepin, a pharmaceutically relevant nucleoside. This review integrates evidence on cultivation, cordycepin biosynthesis and regulation, artificial intelligence and omics applications, recovery, and biological activities, with emphasis on reproducible production and pharmaceutical development. Solid-state and submerged cultivation serve different production targets; however, cordycepin yield and product quality vary with strain, substrate, developmental stage, and process conditions. Cordycepin production depends on biosynthetic activity and protection against deamination associated with the cns1–cns4 cluster, precursor supply, and environmental regulation rather than on gene expression alone. Genetic engineering, metabolic modelling, multi-omics, machine learning, and process monitoring have supported production improvement, pathway analysis or prediction, but these approaches remain poorly integrated. The reviewed studies do not demonstrate validated online cordycepin estimation or autonomous control. Recovery methods involve trade-offs among yield, purity, cost, and throughput, highlighting the need for consistent product specifications. Cordycepin shows anticancer, anti-inflammatory, and antioxidant activities, although evidence remains preclinical and limited by variable experimental exposures, incomplete mechanistic validation, and insufficient pharmacokinetic and clinical data. Future progress requires standardized strains and cultivation protocols, causal metabolic validation, externally validated predictive models, integrated process control, scalable recovery, and translational evaluation.

PharmaceuticalsVol. 19(11)
Qassim University (SA), University of Lucknow (IN), Korea University (KR)
Good health and well-being, Zero hunger
Fungal Biology and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon